WallStreetZenWallStreetZen

NASDAQ: ADTX
Aditxt Inc Stock

Overview
ForecastEarningsRevenueDividendOwnership
$2.50+0.30 (+13.64%)
Updated Apr 17, 2025
ADTX Price
$2.50
Fair Value Price
N/A
Market Cap
$2.90M
52 Week Low
$2.04
52 Week High
$27,200.00
P/E
0x
P/B
5.84x
P/S
4.67x
PEG
N/A
Dividend Yield
N/A
Revenue
$133.99k
Earnings
-$40.35M
Gross Margin
-368.3%
Operating Margin
-26,991.66%
Profit Margin
-34,526.6%
Debt to Equity
48.05
Operating Cash Flow
-$17M
Beta
0.53
Next Earnings
May 19, 2025
Ex-Dividend
N/A
Next Dividend
N/A

ADTX Overview

Aditxt, Inc. is a biotech company developing technologies to improve the health of the immune system by mapping and reprogramming. Its products, AditxtScore and Apoptotic DNA Immunotherapy, mimic the way the body naturally induces tolerance. Aditxt is also developing organ transplant products. The company has a license agreement with Loma Linda University. It was known as ADiTx Therapeutics, Inc. until it changed its name in 2021/07. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, VA.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ADTX's potential to beat the market

DSell
  • Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

F
Value
A
Growth
F
Momentum
C
Sentiment
F
Safety
F
Financials
F
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
ADTX
Ranked#288 of 463

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Protalix Biotherapeutics (PLX)
$2.61A
Aurinia Pharmaceuticals (AUPH)
$7.75A
Rigel Pharmaceuticals (RIGL)
$16.85A
View Top Biotech Stocks

Be the first to know about important ADTX news, forecast changes, insider trades & much more!

ADTX News

Overview

Due Diligence Score

–
Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ADTX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ADTX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ADTX is poor value based on its book value relative to its share price (5.84x), compared to the US Biotechnology industry average (4.05x)
P/B vs Industry Valuation
ADTX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ADTX due diligence checks available for Premium users.

Valuation

ADTX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
0x
Industry
-177.72x
Market
27.98x

ADTX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
5.84x
Industry
4.05x
ADTX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ADTX's financial health

Profit margin

Revenue
$3.2k
Net Income
-$5.2M
Profit Margin
-164,618.2%
ADTX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ADTX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$32.1M
Liabilities
$23.9M
Debt to equity
48.05
ADTX's short-term liabilities ($23.41M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ADTX's short-term assets ($2.00M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ADTX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ADTX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$6.1M
Investing
-$2.7M
Financing
$9.4M
ADTX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ADTX vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ADTXD$2.90M+13.64%-0.00x5.84x
ENVBD$2.89M-4.88%-0.06x1.82x
SNPX–$2.94M-5.37%-0.19x0.50x
REVBD$2.79M+2.67%-0.04x0.59x
LIXT–$3.04M-7.75%-0.71x3.67x
View Top Biotech Stocks

Aditxt Stock FAQ

What is Aditxt's quote symbol?

(NASDAQ: ADTX) Aditxt trades on the NASDAQ under the ticker symbol ADTX. Aditxt stock quotes can also be displayed as NASDAQ: ADTX.

If you're new to stock investing, here's how to buy Aditxt stock.

What is the 52 week high and low for Aditxt (NASDAQ: ADTX)?

(NASDAQ: ADTX) Aditxt's 52-week high was $27,200.00, and its 52-week low was $2.04. It is currently -99.99% from its 52-week high and 22.55% from its 52-week low.

How much is Aditxt stock worth today?

(NASDAQ: ADTX) Aditxt currently has 1,159,200 outstanding shares. With Aditxt stock trading at $2.50 per share, the total value of Aditxt stock (market capitalization) is $2.90M.

Aditxt stock was originally listed at a price of $101,200,000.00 in Jun 30, 2020. If you had invested in Aditxt stock at $101,200,000.00, your return over the last 4 years would have been -100%, for an annualized return of -98.75% (not including any dividends or dividend reinvestments).

How much is Aditxt's stock price per share?

(NASDAQ: ADTX) Aditxt stock price per share is $2.50 today (as of Apr 17, 2025).

What is Aditxt's Market Cap?

(NASDAQ: ADTX) Aditxt's market cap is $2.90M, as of Apr 21, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Aditxt's market cap is calculated by multiplying ADTX's current stock price of $2.50 by ADTX's total outstanding shares of 1,159,200.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.